Back to search results

Psilocybin Therapy for Depression in Parkinson's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Parkinson Disease · Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Brigette Sosa) · pdp2@ucsf.edu · 415-935-3489
    Contact: Study coordinator (Kimberly Sakai) · pdp2@ucsf.edu
    Contact: Principal Investigator (Joshua Woolley, MD,PhD)
    Ellen Bradley, MD (Sub-investigator)
Study leads

  • Joshua Woolley, MD,PhD

    Principal Investigator

    University of California, San Francisco

  • Ellen Bradley, MD

    Principal Investigator

    University of California, San Francisco

View source on ClinicalTrials.gov(opens in a new tab)